OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Gut microbiome features and metabolites in non-alcoholic fatty liver disease among community-dwelling middle-aged and older adults
Fangfang Zeng, Xin Su, Xinxiu Liang, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 15
Fangfang Zeng, Xin Su, Xinxiu Liang, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 15
Showing 15 citing articles:
Updated mechanisms of MASLD pathogenesis
Yuxuan Li, Peipei Yang, Jialu Ye, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 47
Yuxuan Li, Peipei Yang, Jialu Ye, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 47
Modulatory effects of traditional Chinese medicines on gut microbiota and the microbiota-gut-x axis
Tingting Luo, Qingya Che, Ziyi Guo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Tingting Luo, Qingya Che, Ziyi Guo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
The Role of Gut Microbiota in Traditional Chinese Medicine Processing: A General Review
Ruirui Qiao, Ya-Long Chen, Yaya Bai, et al.
Pharmacological Research - Modern Chinese Medicine (2025), pp. 100590-100590
Open Access
Ruirui Qiao, Ya-Long Chen, Yaya Bai, et al.
Pharmacological Research - Modern Chinese Medicine (2025), pp. 100590-100590
Open Access
A critical review of microbiome-derived metabolic functions and translational research in liver diseases
Raja Ganesan, Durairaj Thirumurugan, Saranya Vinayagam, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
Raja Ganesan, Durairaj Thirumurugan, Saranya Vinayagam, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
Fu brick tea supplementation ameliorates non-alcoholic fatty liver disease and associated endotoxemia via maintaining intestinal homeostasis and remodeling hepatic immune microenvironment
Gaolong Zuo, Meng-Hua Li, Xiaoli Guo, et al.
Food Research International (2025), pp. 116207-116207
Closed Access
Gaolong Zuo, Meng-Hua Li, Xiaoli Guo, et al.
Food Research International (2025), pp. 116207-116207
Closed Access
Gut microbiome composition and metabolic activity in metabolic associated fatty liver disease
Daya Zhang, Qi Wang, Da Li, et al.
Virulence (2025)
Open Access
Daya Zhang, Qi Wang, Da Li, et al.
Virulence (2025)
Open Access
Metabolic dysfunction–associated steatotic liver disease and the gut microbiome: pathogenic insights and therapeutic innovations
Bernd Schnabl, Christopher J. Damman, Rotonya M. Carr
Journal of Clinical Investigation (2025) Vol. 135, Iss. 7
Open Access
Bernd Schnabl, Christopher J. Damman, Rotonya M. Carr
Journal of Clinical Investigation (2025) Vol. 135, Iss. 7
Open Access
Best practices for developing microbiome-based disease diagnostic classifiers through machine learning
P Li, Min Li, Wei‐Hua Chen
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access
P Li, Min Li, Wei‐Hua Chen
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access
Interpretable machine learning algorithms reveal gut microbiome features associated with atopic dermatitis
Jing Ma, Yi‐Ting Fang, Shiqi Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Jing Ma, Yi‐Ting Fang, Shiqi Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
The bile acid profile
Zhenhua Liu, Chongge You
Clinica Chimica Acta (2024) Vol. 565, pp. 120004-120004
Closed Access | Times Cited: 3
Zhenhua Liu, Chongge You
Clinica Chimica Acta (2024) Vol. 565, pp. 120004-120004
Closed Access | Times Cited: 3
Metabolomics and Lipidomics for Studying Metabolic Syndrome: Insights into Cardiovascular Diseases, Type 1 & 2 Diabetes, and Metabolic Dysfunction-Associated Steatotic Liver Disease.
Stanislava Rakusanova, Tomáš Čajka
PubMed (2024) Vol. 73, Iss. S1, pp. S165-S183
Closed Access | Times Cited: 1
Stanislava Rakusanova, Tomáš Čajka
PubMed (2024) Vol. 73, Iss. S1, pp. S165-S183
Closed Access | Times Cited: 1
Identification and Validation of a Deep Learning Model for MAFLD Pattern Recognition in Traditional Chinese Medicine, a Prospective Cohort Study
Yu Liang, Hui Zhu, Yuxin Shao, et al.
(2024)
Closed Access
Yu Liang, Hui Zhu, Yuxin Shao, et al.
(2024)
Closed Access
Metabolomics and Lipidomics for Studying Metabolic Syndrome: Insights into Cardiovascular Diseases, Type 1 & 2 Diabetes, and Metabolic Dysfunction-Associated Steatotic Liver Disease
Stanislava Rakusanova, Tomáš Čajka
Physiological Research (2024), Iss. Suppl 1, pp. S165-S183
Open Access
Stanislava Rakusanova, Tomáš Čajka
Physiological Research (2024), Iss. Suppl 1, pp. S165-S183
Open Access
Diagnostic potential of salivary microbiota in persistent pulmonary nodules: identifying biomarkers and functional pathways using 16S rRNA sequencing and machine learning
Xiao Zeng, Qiong Ma, Chun-Xia Huang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access
Xiao Zeng, Qiong Ma, Chun-Xia Huang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access
Valorizing Agro‐Food Waste for Nutraceutical Development: Sustainable Approaches for Managing Metabolic Dysfunction‐Associated Steatotic Liver Disease and Related Co‐Morbidities
Laura Comi, Claudia Giglione, Fationa Tolaj, et al.
Food Frontiers (2024)
Open Access
Laura Comi, Claudia Giglione, Fationa Tolaj, et al.
Food Frontiers (2024)
Open Access
